Boston Scientific Still Recovering From Cyberattack
Boston Scientific is experiencing significant operational disruptions following a cyberattack that impacted its IT systems, leading to a network outage and delays in product shipments. While the attack didn't affect existing implantable devices, it has severely hampered the company's ability to operate effectively. The investigation is ongoing, and the perpetrators remain unknown.
Boston Scientific is currently grappling with substantial operational setbacks following a significant cyberattack that penetrated its internal IT systems. The incident, detected on August 25th and publicly disclosed the following day, triggered a widespread network outage, severely impacting global operations including product manufacturing, customer order processing, and shipping activities. The company develops and manufactures medical devices and therapies primarily used in cardiology, neurology, and oncology fields. Despite the disruption, Boston Scientific clarified that the attack did not compromise existing implantable cardiac rhythm management (CRM) devices. However, it did impede new remote activations for certain cardiac monitors. Cybersecurity firms, including CrowdStrike, have been engaged to assist with the investigation and remediation efforts. Recent updates indicate that the company has not detected any further malicious activity on its networks since August 25th, suggesting the breach was contained to a subset of on-premises systems. Boston Scientific anticipates a partial resumption of product shipments this week, though a full restoration timeline remains uncertain. The identity of the attacker remains unknown, with no known cybercrime group claiming responsibility for the breach.